User login
This year’s annual Assocaition of VA Hematology and Oncology (AVAHO) conference offers nearly 50 sessions over the course of 3 days that focus on providing evidence-based hematology and oncology practice. According to AVAHO President Mary Thomas, MS, “I am hopeful that people come away from this meeting with a different conception of evidence-based practice and how they might apply it.”
John P.A. Ioannidis, MD, DSc, the C. F. Rehnborg Professor in Disease Prevention in the School of Medicine and Professor of Health Research and Policy (Epidemiology) at Stanford University will offer the opening keynote address on integrating evidence into patient care. According to Ms. Thomas, Dr. Ioannidis is a “provocative speaker” who may challenge conceptions and execution of evidence-based practice. Other keynote addresses will be presented by Steve Harvey, vice president of IBM Watson Health, to discuss the use of artificial intelligence in health care and specifically cancer care and playwright Maggie Edson, winner of a Pulitzer Prize for the play “Wit.” Ms. Edson’s presentation should provide a unique look at the patient experience and a new consideration of patients’ perspectives and values.
The full agenda can be found here: http://www.avaho.org/2017-annual-meeting.html
This year’s annual Assocaition of VA Hematology and Oncology (AVAHO) conference offers nearly 50 sessions over the course of 3 days that focus on providing evidence-based hematology and oncology practice. According to AVAHO President Mary Thomas, MS, “I am hopeful that people come away from this meeting with a different conception of evidence-based practice and how they might apply it.”
John P.A. Ioannidis, MD, DSc, the C. F. Rehnborg Professor in Disease Prevention in the School of Medicine and Professor of Health Research and Policy (Epidemiology) at Stanford University will offer the opening keynote address on integrating evidence into patient care. According to Ms. Thomas, Dr. Ioannidis is a “provocative speaker” who may challenge conceptions and execution of evidence-based practice. Other keynote addresses will be presented by Steve Harvey, vice president of IBM Watson Health, to discuss the use of artificial intelligence in health care and specifically cancer care and playwright Maggie Edson, winner of a Pulitzer Prize for the play “Wit.” Ms. Edson’s presentation should provide a unique look at the patient experience and a new consideration of patients’ perspectives and values.
The full agenda can be found here: http://www.avaho.org/2017-annual-meeting.html
This year’s annual Assocaition of VA Hematology and Oncology (AVAHO) conference offers nearly 50 sessions over the course of 3 days that focus on providing evidence-based hematology and oncology practice. According to AVAHO President Mary Thomas, MS, “I am hopeful that people come away from this meeting with a different conception of evidence-based practice and how they might apply it.”
John P.A. Ioannidis, MD, DSc, the C. F. Rehnborg Professor in Disease Prevention in the School of Medicine and Professor of Health Research and Policy (Epidemiology) at Stanford University will offer the opening keynote address on integrating evidence into patient care. According to Ms. Thomas, Dr. Ioannidis is a “provocative speaker” who may challenge conceptions and execution of evidence-based practice. Other keynote addresses will be presented by Steve Harvey, vice president of IBM Watson Health, to discuss the use of artificial intelligence in health care and specifically cancer care and playwright Maggie Edson, winner of a Pulitzer Prize for the play “Wit.” Ms. Edson’s presentation should provide a unique look at the patient experience and a new consideration of patients’ perspectives and values.
The full agenda can be found here: http://www.avaho.org/2017-annual-meeting.html
